Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SMISEK JEFFERY A
Finch Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Chidozie Ugwumba(9.99%)
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SMISEK JEFFERY A
Finch Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Blischak Matthew P.
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Blischak Matthew P.
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lange Christian H.
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SMISEK JEFFERY A
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Haft Nicholas
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FERRANTE DOMENIC J
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Graf Susan E
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Shumway Chris
Finch Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer Blischak Matthew P.
Finch Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer THIBAULT LANCE E
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities
No Data